Passage BIO, Inc.
PASG- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001787297
No open-market purchases or sales by Passage BIO, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.82M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Passage BIO, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- −1 vs. Q3 2025
- Shares held
- 1.58M
- +15.9K (+1.0%) vs. Q3 2025
- Total value
- $18.6M
- +$6.06M (+48.3%) vs. Q3 2025
- New holders
- 6
- 5 more added
- Sold out
- 7
- 6 more reduced
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PASG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $6.82M |
| Q1 2026 | 35 | $13.8M |
| Q4 2025 | 30 | $18.6M |
| Q3 2025 | 32 | $13.2M |
| Q2 2025 | 41 | $13.0M |
| Q1 2025 | 42 | $12.8M |
| Q4 2024 | 46 | $21.6M |
| Q3 2024 | 45 | $27.1M |
| Q2 2024 | 45 | $32.0M |
| Q1 2024 | 51 | $54.4M |
| Q4 2023 | 52 | $33.1M |
| Q3 2023 | 51 | $21.3M |
| Q2 2023 | 56 | $31.4M |
| Q1 2023 | 59 | $34.0M |
| Q4 2022 | 68 | $51.6M |
| Q3 2022 | 76 | $49.3M |
| Q2 2022 | 87 | $99.6M |
| Q1 2022 | 110 | $133.2M |
| Q4 2021 | 102 | $277.7M |
| Q3 2021 | 103 | $419.1M |
| Q2 2021 | 102 | $558.8M |
| Q1 2021 | 90 | $786.5M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Passage BIO, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CWM, LLC | 1 | $0 | 0.00% | −1−50.0% | Reduced |
| TSFG, LLC | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 3 | $35 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 12 | $142 | 0.00% | 00.0% | Unchanged |
| LRI Investments, LLC | 12 | $142 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 15 | $177 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 16 | $189 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 20 | $236 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 28 | $331 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 142 | $1.68K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 212 | $2.50K | 0.00% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 500 | $5.90K | 0.00% | +500 | New |
| UBS Group AG | 1,442 | $17.0K | 0.00% | +1,425+8,382.4% | Added |
| Morgan Stanley | 4,275 | $50.4K | 0.00% | +3,937+1,164.8% | Added |
| Nano Cap New Millennium Growth Fund L P | 10,000 | $118.0K | 0.10% | +10,000 | New |
| Fiduciary Trust Co | 10,750 | $126.8K | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 10,799 | $127.4K | 0.00% | −12,701−54.0% | Reduced |
| Quadrature Capital Ltd | 12,578 | $148.4K | 0.00% | +12,578 | New |
| Northern Trust Corp | 14,217 | $167.8K | 0.00% | +14,217 | New |
| Citadel Advisors LLC | 17,660 | $208.4K | 0.00% | −1,431−7.5% | Reduced |
| Acadian Asset Management LLC | 24,196 | $284.0K | 0.00% | −1,372−5.4% | Reduced |
| BlackRock, Inc. | 28,903 | $341.1K | 0.00% | −846−2.8% | Reduced |
| Geode Capital Management, LLC | 31,397 | $370.6K | 0.00% | +4,114+15.1% | Added |
| Yiheng Capital Management, L.P. | 34,301 | $404.8K | 0.18% | +34,301 | New |
| Erste Asset Management GmbH | 85,262 | $1.00M | 0.01% | −37,528−30.6% | Reduced |
| Renaissance Technologies LLC | 109,089 | $1.29M | 0.00% | +8,300+8.2% | Added |
| Eversept Partners, LP | 126,230 | $1.49M | 0.08% | +126,230 | New |
| Vanguard Group Inc | 126,645 | $1.49M | 0.00% | +9,615+8.2% | Added |
| Vestal Point Capital, LP | 305,000 | $3.60M | 0.13% | 00.0% | Unchanged |
| Lynx1 Capital Management LP | 623,704 | $7.36M | 1.49% | 00.0% | Unchanged |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −59,046−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −20,803−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −289−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −77−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| New Leaf Venture Partners, L.L.C. | – | – | – | – | Not filed |